AS1411

DRUG4 trials

Sponsors

Antisoma Research

Conditions

Acute Myeloid LeukemiaAdvanced Solid TumorsLeukemia, MyeloidMetastatic Renal Cell Carcinoma

Phase 1

Study of AS1411 in Advanced Solid Tumours

CompletedNCT00881244

Antisoma ResearchAdvanced Solid Tumors

Start: 2003-09-30End: 2007-02-28Updated: 2009-04-15

Phase 2

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

CompletedNCT00512083

Antisoma ResearchLeukemia, Myeloid

Start: 2007-07-31Target: 70Updated: 2009-09-25

A Phase II Study of AS1411 in Renal Cell Carcinoma

Antisoma ResearchMetastatic Renal Cell Carcinoma

Start: 2008-08-31End: 2010-03-31Target: 30Updated: 2009-09-25

A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

TerminatedNCT01034410

Antisoma ResearchAcute Myeloid Leukemia

Start: 2010-01-31End: 2011-01-31Target: 90Updated: 2011-02-02